Tags

Type your tag names separated by a space and hit enter

Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report.
Eur Heart J Case Rep. 2020 Jun; 4(3):1-7.EH

Abstract

Background

About 7% of amyloid A (AA) amyloidosis cases are accompanied by heart disease. Although several studies have recently reported that specific biologicals improved renal function in AA amyloidosis, little evidence is available regarding heart disease in AA amyloidosis.

Case summary

A 57-year-old woman with rheumatoid arthritis presented with sudden worsening of renal function. Echocardiography revealed granular sparkling appearance in the ventricular septum and posterior wall (PW). Echocardiography indicated left ventricular (LV) diastolic dysfunction. Global longitudinal strain (GLS) exhibited an apical sparing pattern. Cardiac biopsy demonstrated amyloid A deposition on immunostaining. Soluble tumour necrosis factor-alpha receptor etanercept therapy was initiated. Four years later, echocardiography showed improved diastolic function, including E/A and E/e', and decreased wall thickness in both the interventricular septum and PW of the left ventricle. Granular sparkling appearance had diminished. Moreover, the LV dysfunction improved on GLS. Five years later, the medication was gradually losing effect and the patient had worsening pain in the joints; moreover, articular destruction was observed on radiography. The patient was switched to abatacept therapy. Echocardiography showed recurrence of LV hypertrophy and electrocardiogram showed down-sloped ST depression in V4-6 leads.

Discussion

This case indicates that etanercept can be effective for heart disease in AA amyloidosis. Of particular, interest is the improvement of granular sparkling appearance in addition to cardiac function improvement noted in this case.

Authors+Show Affiliations

Division of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.Division of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.Division of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.

Pub Type(s)

Case Reports

Language

eng

PubMed ID

32617472

Citation

Miyagawa, Sawa, et al. "Soluble Tumour Necrosis Factor-alpha Receptor Improved the Function, Hypertrophy, and Granular Sparkling Appearance of the Left Ventricular Myocardium in Systemic Amyloid a Amyloidosis: a Case Report." European Heart Journal. Case Reports, vol. 4, no. 3, 2020, pp. 1-7.
Miyagawa S, Miyamoto T, Sato Y. Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report. Eur Heart J Case Rep. 2020;4(3):1-7.
Miyagawa, S., Miyamoto, T., & Sato, Y. (2020). Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report. European Heart Journal. Case Reports, 4(3), 1-7. https://doi.org/10.1093/ehjcr/ytaa048
Miyagawa S, Miyamoto T, Sato Y. Soluble Tumour Necrosis Factor-alpha Receptor Improved the Function, Hypertrophy, and Granular Sparkling Appearance of the Left Ventricular Myocardium in Systemic Amyloid a Amyloidosis: a Case Report. Eur Heart J Case Rep. 2020;4(3):1-7. PubMed PMID: 32617472.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report. AU - Miyagawa,Sawa, AU - Miyamoto,Tadashi, AU - Sato,Yukihito, Y1 - 2020/03/16/ PY - 2019/04/15/received PY - 2019/05/22/revised PY - 2020/02/12/accepted PY - 2020/7/4/entrez PY - 2020/7/4/pubmed PY - 2020/7/4/medline KW - Cardiac amyloidosis KW - Case report KW - Diastolic function KW - Granular sparkling appearance KW - Soluble TNF-alpha receptor SP - 1 EP - 7 JF - European heart journal. Case reports JO - Eur Heart J Case Rep VL - 4 IS - 3 N2 - Background: About 7% of amyloid A (AA) amyloidosis cases are accompanied by heart disease. Although several studies have recently reported that specific biologicals improved renal function in AA amyloidosis, little evidence is available regarding heart disease in AA amyloidosis. Case summary: A 57-year-old woman with rheumatoid arthritis presented with sudden worsening of renal function. Echocardiography revealed granular sparkling appearance in the ventricular septum and posterior wall (PW). Echocardiography indicated left ventricular (LV) diastolic dysfunction. Global longitudinal strain (GLS) exhibited an apical sparing pattern. Cardiac biopsy demonstrated amyloid A deposition on immunostaining. Soluble tumour necrosis factor-alpha receptor etanercept therapy was initiated. Four years later, echocardiography showed improved diastolic function, including E/A and E/e', and decreased wall thickness in both the interventricular septum and PW of the left ventricle. Granular sparkling appearance had diminished. Moreover, the LV dysfunction improved on GLS. Five years later, the medication was gradually losing effect and the patient had worsening pain in the joints; moreover, articular destruction was observed on radiography. The patient was switched to abatacept therapy. Echocardiography showed recurrence of LV hypertrophy and electrocardiogram showed down-sloped ST depression in V4-6 leads. Discussion: This case indicates that etanercept can be effective for heart disease in AA amyloidosis. Of particular, interest is the improvement of granular sparkling appearance in addition to cardiac function improvement noted in this case. SN - 2514-2119 UR - https://www.unboundmedicine.com/medline/citation/32617472/Soluble_tumour_necrosis_factor-alpha_receptor_improved_the_function,_hypertrophy,_and_granular_sparkling_appearance_of_the_left_ventricular_myocardium_in_systemic_amyloid_A_amyloidosis:_a_case_report DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.